Another major challenge for the market peptide synthesis

(2023年)

Restraints:
The high cost associated with peptide synthesis is a major restraint for the market. The cost of raw materials, equipment, and labor is high, which makes peptide synthesis expensive. In addition, the complexity of peptide synthesis and the need for highly skilled personnel is a major challenge for the market.

Another major challenge for the market is the lack of regulatory guidelines for peptide therapeutics. The lack of clear guidelines and regulations for the development and commercialization of peptide therapeutics is hindering the growth of the market.

Growth Projections:

The peptide synthesis market is expected to register a CAGR of 7.2 % over the forecast period and revenue is projected to increase from USD 506.2 Million in 2021 to USD 954.3 Million in 2030. The increasing demand for peptide therapeutics for the treatment of chronic diseases such as cancer and diabetes is expected to drive the growth of the market.